Showing results (31-40 of 51) with videos related to
Sort By:
Pageof 6
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 4, 2006
Natural history of patients hospitalized for management of cirrhotic ascitesRamon Planas, Silvia Montoliu, Belen Ballesté, et al.Journal of Hepatology|March 24, 2009
Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosisCristina Ripoll, Roberto J Groszmann, Guadalupe Garcia-Tsao, et al.Medicina Clinica|May 25, 2002
[Induction therapy with interferon alfa-2a in compensated hepatitis C virus-related cirrhosis. Randomized, multicenter study]Ramon Planas, Juan Carlos Quer, Jaime Enríquez, et al.Antiviral Therapy|January 18, 2005
Mitochondrial effects of a 24-week course of pegylated-interferon plus ribavirin in asymptomatic HCV/HIV co-infected patients on long-term treatment with didanosine, stavudine or bothAngel Luis Ballesteros, Oscar Miró, Sònia López, et al.Antiviral Therapy|November 30, 2005
Short communication. Baseline factors associated with haematological toxicity that leads to a dosage reduction of pegylated interferon-alpha2a and ribavirin in HIV- and HCV-coinfected patients on HCV antiviral therapyDaniel Fuster, Jaime A Huertas, Guadalupe Gómez, et al.The New England Journal of Medicine|November 25, 2005
Beta-blockers to prevent gastroesophageal varices in patients with cirrhosisRoberto J Groszmann, Guadalupe Garcia-Tsao, Jaime Bosch, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 20, 2010
Incidence and prognosis of different types of functional renal failure in cirrhotic patients with ascitesSilvia Montoliu, Belén Ballesté, Ramon Planas, et al.The Journal of Clinical Psychiatry|November 2, 2010
Prophylactic treatment with escitalopram of pegylated interferon alfa-2a-induced depression in hepatitis C: a 12-week, randomized, double-blind, placebo-controlled trialCrisanto Diez-Quevedo, Helena Masnou, Ramon Planas, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 28, 2009
Accuracy of simple biochemical tests in identifying liver fibrosis in patients co-infected with human immunodeficiency virus and hepatitis C virusCristina Tural, Jordi Tor, Arantza Sanvisens, et al.AIDS Research and Human Retroviruses|January 15, 2005
Advanced liver fibrosis in HIV/HCV-coinfected patients on antiretroviral therapyDaniel Fuster, Ramon Planas, Robert Muga, et al.Pageof 6